Health Care REIT prices underwritten public offering of common stock

Health Care REIT, Inc. (NYSE:HCN) today announced the pricing of its underwritten public offering of 11,000,000 shares of common stock at $50.00 per share. The offering was increased in size from 10,000,000 shares in response to investor demand. The company has granted the underwriters an option to purchase up to an additional 1,650,000 shares during the next 30 days to cover over-allotments, if any. The company estimates that the gross proceeds from this offering will be approximately $550.0 million (or approximately $632.5 million if the underwriters' over-allotment option is exercised in full).

The company intends to use the net proceeds from this offering for general corporate purposes, including investing in health care and seniors housing properties and repaying borrowings under the company's unsecured line of credit and other outstanding indebtedness.

Source:

Health Care REIT, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How innovation in dried blood spot testing is transforming neurological disease monitoring